GSDMD was significantly upregulated in Bladder Urothelial Carcinoma (BLCA), Breast Cancer (BRCA), and other tumors, while it was notably downregulated in Colon Adenocarcinoma (COAD), Kidney Chromosome (KICH), and several others. Here, GSDMD is linked to colon adenocarcinoma.